Treatment Regimen for Anterior Uveitis
For anterior uveitis, initiate topical prednisolone acetate 1% eye drops as first-line therapy, with ophthalmology follow-up within 2 days if symptomatic (Grade 2), and reserve oral prednisolone for severe cases or when topical therapy fails. 1
Topical Corticosteroid Dosing
Prednisolone acetate 1% is the preferred topical agent over dexamethasone due to superior corneal penetration 2. The typical regimen involves:
- Initial intensive dosing: Start with frequent drops (every 1-2 hours while awake) for acute inflammation
- Taper based on response: Reduce frequency as anterior chamber cells decrease
- Goal: Maintain control with ≤1-2 drops/day or discontinue entirely
Critical Threshold for Escalation
If you require ≥2 drops/day of prednisolone acetate 1% for more than 3 months to maintain control, you must add systemic therapy 2. This threshold exists because:
- ≥2 drops/day significantly increases risk of elevated intraocular pressure 2
- ≤3 drops daily preferred over ≥4 drops to reduce cataract risk 2
- ≤1 drop/day carries no excess risk of cataract or IOP elevation compared to no drops 3
Oral Prednisolone: When and How Much
Oral prednisolone is NOT first-line for uncomplicated anterior uveitis 1. Reserve systemic corticosteroids for:
- Grade 3+ disease: Posterior or pan-uveitis with marked vision loss
- Bilateral sight-threatening disease
- Failure of topical therapy in anterior uveitis
Dosing When Indicated
From FDA labeling 4:
- Initial dose range: 5-60 mg/day (0.14-2 mg/kg/day in children) depending on severity
- Typical adult dose for moderate-severe uveitis: 30-60 mg/day initially
- Duration: Continue until adequate response, then taper gradually
- Never stop abruptly after long-term use
The evidence shows that for acute exacerbations requiring systemic therapy, 200 mg daily for 1 week followed by 80 mg every other day has been effective in other inflammatory conditions 4, though this specific regimen is for multiple sclerosis and may not directly apply to anterior uveitis.
Ophthalmology Follow-Up Schedule
Timing depends on disease severity 1:
For Symptomatic Anterior Uveitis (Grade 2):
- Within 2 days of initiating treatment
- Coordinate topical corticosteroid dosing with ophthalmologist
- Add cycloplegic agents as directed
During Topical Steroid Taper:
- Within 1 month after each change in topical glucocorticoid dosing 2
- This is a strong recommendation from the ACR/Arthritis Foundation guidelines
On Stable Therapy:
- Every 3 months minimum 2
If Adding/Changing Systemic Therapy:
- Within 2 months of any systemic therapy change 2
Common Pitfalls to Avoid
Starting oral prednisolone before ophthalmology exam: This can mask infectious causes (e.g., herpetic keratitis) and worsen outcomes 1
Using dexamethasone drops instead of prednisolone acetate 1%: Prednisolone acetate has better corneal penetration and is preferred 2
Continuing topical steroids at ≥2 drops/day long-term: This dramatically increases IOP and cataract risk without adding systemic therapy 2, 3
Inadequate follow-up frequency: Missing the 2-day window for symptomatic patients or monthly monitoring during tapers risks complications 2, 1
Abrupt discontinuation: Always taper corticosteroids gradually, whether topical or systemic 4
When to Escalate Beyond Corticosteroids
Consider systemic immunosuppression (methotrexate, biologics) if:
- Requiring 1-2 drops/day prednisolone acetate 1% for ≥3 months 2
- Developing corticosteroid complications (elevated IOP, cataracts)
- Recurrent flares despite adequate topical therapy
- Bilateral disease requiring prolonged treatment 5
The goal is always to achieve complete control of inflammation while minimizing corticosteroid exposure to prevent vision-threatening complications from both the disease and its treatment 2.